Yaribeygi et al. concluded that resolvins inhibited the formation of NLRP3 inflammasome and NF-κB pathway and recruited inflammatory cells, thereby relieving oxidative stress and alleviating DN [71]. The gene discussed is NLRP3; the disease is liver dysplastic nodule.